Effect of particle size on the biodistribution of lipid nanocapsules: Comparison between nuclear and fluorescence imaging and counting

International Journal of Pharmaceutics

Volumn 453, Issue 2, 2013, Pages 594-600

  Hirsjärvi, Samuli ^a   Sancey, Lucie ^b,c   Dufort, Sandrine ^b   Belloche, Camille ^a   Vanpouille Box, Claire ^a,d   Garcion, Emmanuel ^a   Coll, Jean Luc ^b   Hindré, François ^a   Benoit̂, Jean Pierre ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c UNIVERSITÉ LYON 1   (France)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biodistribution; Fluorescence; Lipid nanocapsules; Optical imaging; Scintigraphy

Indexed keywords

NANOCAPSULE; NANOCARRIER; SOLID LIPID NANOPARTICLE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CIRCULATION; ELECTRON SPIN RESONANCE; EMBRYO; FEMALE; FLUORESCENCE IMAGING; GAMMA COUNTER; GAMMA SCINTIGRAPHY; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERMETHOD COMPARISON; ISOTOPE LABELING; KIDNEY; LIVER; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPLEEN; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

EID: 84884124839     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.05.057     Document Type: Article

References (57)

1. Allard, E., Hindre, F., Passirani, C., Lemaire, L., Lepareur, N., Noiret, N., Menei, P., Benoit, J.P., 2008. Re-188-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas. Eur. J. Nucl. Med. Mol. Imag. 35, 1838-1846.
2. Baker, M., 2010. Whole-animal imaging: the whole picture. Nature 463, 977-980.
3. 188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution. Eur. J. Nucl. Med. Mol. Imag. 33, 602-607.
4. Béduneau, A., Hindré, F., Clavreul, A., Leroux, J.-C., Saulnier, P., Benoit, J.-P., 2008. Brain targeting using novel lipid nanovectors. J. Control. Release 126, 44-49. (Pubitemid 351175685)
5. Béduneau, A., Saulnier, P., Hindré, F., Clavreul, A., Leroux, J.-C., Benoit, J.-P., 2007. Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. Biomaterials 28, 4978-4990. (Pubitemid 47371148)
6. Bourseau-Guilmain, E., Béjaud, J., Griveau, A., Lautram, N., Hindré, F., Weyland, M., Benoit, J.P., Garcion, E., 2012. Development and characterization of immunonanocarriers targeting the cancer stem cell marker AC133. Int. J. Pharm. 423, 93-101.
7. Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M.R., Miyazono, K., Uesaka, M., Nishiyama, N., Kataoka, K., 2011. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 6, 815-823.
8. Choi, C.H.J., Zuckerman, J.E., Webster, P., Davis, M.E., 2011. Targeting kidney mesangium by nanoparticles of defined size. Proc. Natl. Acad. Sci. 108, 6656-6661.
9. Choi, H.S., Wenhao, L., Misra, P., Tanaka, E., Zimmer, J.P., Ipe, B.I., Bawendi, M.G., Frangioni, J.V., 2007. Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165-1170. (Pubitemid 47538116)
10. Cirpanli, Y., Allard, E., Passirani, C., Bilensoy, E., Lemaire, L., Calis, S., Benoit, J.- P., 2011. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model. Int. J. Pharm. 403, 201-206.
11. De Jong, W.H., Hagens, W.I., Krystek, P., Burger, M.C., Sips, A.J.A.M., Geertsma, R.E., 2008. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29, 1912-1919.
12. de Wolf, H.K., Snel, C.J., Verbaan, F.J., Schiffelers, R.M., Hennink, W.E., Storm, G., 2007. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. Int. J. Pharm. 331, 167-175. (Pubitemid 46216670)
13. Dufort, S., Sancey, L., Wenk, C., Josserand, V., Coll, J.L., 2010. Optical small animal imaging in the drug discovery process. Biochim. Biophys. Acta 1798, 2266-2273.
14. Farokhzad, O.C., Langer, R., 2009. Impact of nanotechnology on drug delivery. ACS Nano 3, 16-20.
15. Garcion, E., Lamprecht, A., Heurtault, B., Paillard, A., Aubert-Pouessel, A., Denizot, B., Menei, P., Benoit, J.P., 2006. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol. Cancer Ther. 5, 1710-1722. (Pubitemid 44323239)
16. Goutayer, M., Dufort, S., Josserand, V., Royère, A., Heinrich, E., Vinet, F., Bibette, J., Coll, J.-L., Texier, I., 2010. Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur. J. Pharm. Biopharm. 75, 137-147.
17. He, C., Hu, Y., Yin, L., Tang, C., Yin, C., 2010. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31, 3657-3666.
18. Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E., Benoit, J.-P., 2002. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19, 875-880. (Pubitemid 34692585)
19. Heurtault, B., Saulnier, P., Pech, B., Venier-Julienne, M.-C., Proust, J.-E., Phan-Tan-Luu, R., Benoit, J.-P., 2003. The influence of lipid nanocapsule composition on their size distribution. Eur. J. Pharm. Sci. 18, 55-61. (Pubitemid 36120555)
20. Hirn, S., Semmler-Behnke, M., Schleh, C., Wenk, A., Lipka, J., Schäffler, M., Takenaka, S., Möller, W., Schmid, G., Simon, U., Kreyling, W.G., 2011. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur. J. Pharm. Biopharm. 77, 407-416.
21. Hirsjärvi, S., Dufort, S., Gravier, J., Texier, I., Qiao, Y., Bibette, J., Sancey, L., Josserand, V., Passirani, C., Benoit, J.-P., Coll, J.-L., 2013. Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models. Nanomedicine: NBM 9, 375-387.
22. Hirsjärvi, S., Passirani, C., Benoit, J.-P., 2011. Passive and active tumour targeting with nanocarriers. Curr. Drug Discov. Technol. 8, 188-196.
23. Hoarau, D., Delmas, P., David, S., Roux, E., Leroux, J.-C., 2004. Novel long-circulating lipid nanocapsules. Pharm. Res. 21, 1783-1789. (Pubitemid 39390089)
24. 3 in mice using multivalent or monovalent cRGD targeting vectors. Mol. Cancer 6, 41.
25. Kim, J.-Y., Choi, W.I., Kim, Y.H., Tae, G., Lee, S.-Y., Kim, K., Kwon, I.C., 2010. Invivo tumor targeting of pluronic-based nano-carriers. J. Control. Release 147, 109-117.
26. Kircheis, R., Ostermann, E., Wolschek, M.F., Lichtenberger, C., Magin-Lachmann, C., Wightman, L., Kursa, M., Wagner, E., 2002. Tumor-targeted gene delivery of tumor necrosis factor-α induces tumor necrosis and tumor regression without systemic toxicity. Cancer Gene Ther. 9, 673-680. (Pubitemid 34847575)
27. Kumari, A., Yadav, S.K., Yadav, S.C., 2010. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B 75, 1-18.
28. Kursa, M., Walker, G.F., Roessler, V., Ogris, M., Roedl, W., Kircheis, R., Wagner, E., 2002. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug. Chem. 14, 222-231. (Pubitemid 36169036)
29. Lacoeuille, F., Hindré, F., Moal, F., Roux, J., Passirani, C., Couturier, O., Cales, P., Le Jeune, J.J., Lamprecht, A., Benoit, J.P., 2007. In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int. J. Pharm. 344, 143-149. (Pubitemid 47464828)
30. Lamprecht, A., Saumet, J.-L., Roux, J., Benoit, J.-P., 2004. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int. J. Pharm. 278, 407-414. (Pubitemid 38759512)
31. Lee, H., Fonge, H., Hoang, B., Reilly, R.M., Allen, C., 2010. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol. Pharm. 7, 1195-1208.
32. Meng, H., Xue, M., Xia, T., Ji, Z., Tarn, D.Y., Zink, J.I., Nel, A.E., 2011. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 5, 4131-4144.
33. Mévellec, F., Tisato, F., Refosco, F., Roucoux, A., Noiret, N., Patin, H., Bandoli, G., 2002. Synthesis and characterization of the "sulfur-rich" bis (perthiobenzoato) (dithiobenzoato) technetium (III) heterocomplex. Inorg. Chem. 41, 598-601.
34. Morille, M., Montier, T., Legras, P., Carmoy, N., Brodin, P., Pitard, B., Benoit, J.-P., Passirani, C., 2010. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials 31, 321-329.
35. Morille, M., Passirani, C., Dufort, S., Bastiat, G., Pitard, B., Coll, J.-L., Benoit, J.-P., 2011. Tumor transfection after systemic injection of DNA lipid nanocapsules. Biomaterials 32, 2327-2333.
36. Müller, R.H., Shegokar, R., Keck, C.M., 2011. 20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications. Curr. Drug Discov. Technol. 8, 207-227.
37. Na, J.H., Koo, H., Lee, S., Min, K.H., Park, K., Yoo, H., Lee, S.H., Park, J.H., Kwon, I.C., Jeong, S.Y., Kim, K., 2011. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. Biomaterials 32, 5252-5261.
38. Paillard, A., Hindré, F., Vignes-Colombeix, C., Benoit, J.-P., Garcion, E., 2010. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials 31, 7542-7554.
39. Peltier, S., Oger, J.-M., Lagarce, F., Couet, W., Benoit, J.-P., 2006. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm. Res. 23, 1243-1250. (Pubitemid 43946146)
40. Perrault, S.D., Walkey, C., Jennings, T., Fischer, H.C., Chan, W.C.W., 2009. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 9, 1909-1915.
41. Razkin, J., Josserand, V., Boturyn, D., Jin Z.-h. Dumy, P., Favrot, M., Coll, J.-L., Texier, I., 2006. Activatable fluorescent probes for tumour-targeting imaging in live mice. ChemMedChem 1, 1069-1072. (Pubitemid 44622247)
42. Sancey, L., Dufort, S., Josserand, V., Keramidas, M., Righini, C., Rome, C., Faure, A.C., Foillard, S., Roux, S., Boturyn, D., Tillement, O., Koenig, A., Boutet, J., Rizo, P., Dumy, P., Coll, J.L., 2009. Drug development in oncology assisted by noninvasive optical imaging. Int. J. Pharm. 379, 309-316.
43. Schädlich, A., Caysa, H., Mueller, T., Tenambergen, F., Rose, C., Göpferich, A., Kuntsche, J., Mäder, K., 2011a. Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model. ACS Nano 5, 8710-8720.
44. Schädlich, A., Hoffmann, S., Mueller, T., Caysa, H., Rose, C., Göpferich, A., Li, J., Kuntsche, J., Mäder, K., 2012. Accumulation of nanocarriers in the ovary: a neglected toxicity risk. J. Control. Release 160, 105-112.
45. Schädlich, A., Rose, C., Kuntsche, J., Caysa, H., Mueller, T., Göpferich, A., Mäder, K., 2011b. How stealthy are PEG-PLA nanoparticles? An NIR in vivo study combined with detailed size measurements. Pharm. Res. 28, 1995-2007.
46. Sonavane, G., Tomoda, K., Makino, K., 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf. B 66, 274-280.
47. Sun, X., Rossin, R., Turner, J.L., Becker, M.L., Joralemon, M.J., Welch, M.J., Wooley, K.L., 2005. An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution. Biomacromolecules 6, 2541-2554. (Pubitemid 41388265)
48. Torchilin, V., 2007. Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 24, 1-16. (Pubitemid 44902565)
49. Torchilin, V.P., 2005. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4, 145-160. (Pubitemid 40282557)
50. Vanpouille-Box, C., Lacoeuille, F., Belloche, C., Lepareur, N., Lemaire, L., LeJeune, J.-J., Benoit, J.-P., Menei, P., Couturier, O.F., Garcion, E., Hindré, F., 2011a. Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with 188Re-lipid nanocapsules. Biomaterials 32, 6781-6790.
51. Vanpouille-Box, C., Lacoeuille, F., Roux, J., Aubé, C., Garcion, E., Lepareur, N., Oberti, F., Bouchet, F., Noiret, N., Garin, E., Benoit, J.-P., Couturier, O., Hindré, F., 2011b. Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model. PLoS ONE 6, e16926.
52. Weyland, M., Manero, F., Paillard, A., Grée, D., Viault, G., Jarnet, D., Menei, P., Juin, P., Chourpa, I., Benoit, J.P., Grée, R., Garcion, E., 2011. Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1. J. Control. Release 151, 74-82.
53. Vonarbourg, A., Passirani, C., Saulnier, P., Benoit, J.-P., 2006. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 27, 4356-4373. (Pubitemid 43674179)
54. Vonarbourg, A., Saulnier, P., Passirani, C., Benoit, J.-P., 2005. Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface. Electrophoresis 26, 2066-2075. (Pubitemid 40852638)
55. Yang, Z., Leon, J., Martin, M., Harder, J.W., Zhang, R., Liang, D., Lu, W., Tian, M., Gelovani, J.G., Qiao, A., Li, C., 2009. Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles. Nanotechnology 20, 165101.
56. Yang, Z., Zheng, S., Harrison, W.J., Harder, J., Wen, X., Gelovani, J.G., Qiao, A., Li, C., 2007. Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging. Biomacromolecules 8, 3422-3428. (Pubitemid 350193742)
57. Zou, J., Saulnier, P., Perrier, T., Zhang, Y., Manninen, T., Toppila, E., Pyykkö, I., 2008. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. J. Biomed. Mater. Res. B 87B, 10-18.